Insilico Medicine has announced the discovery of a highly selective PKMYT1 inhibitor, designed using its AI-driven Chemistry42 platform, that could advance cancer therapy. The compound, A4-ent1, ...
This article and associated images are based on a poster originally authored by Nermeen Ali, Heather Coleman, Azza Taher, Marwa Sarg and Noha Hilmy Elnagdi and presented at ELRIG Drug Discovery 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results